Alzheimer’s disease EU-IN Horizon Scanning Report

3-year work plan for the Biologics Working Party (BWP) 2026-2028

Human medicines European public assessment report (EPAR): Aubagio, teriflunomide, Date of authorisation: 26/08/2013, Revision: 30, Status: Authorised

Development and manufacture of synthetic peptides - Scientific guideline

Guideline on the development and manufacture of synthetic peptides

15th industry stakeholder platform on research and development support, European Medicines Agency, Amsterdam, the Netherlands, from 4 December 2025, 12:30 (CET) to 4 December 2025, 17:30 (CET)

Human medicines European public assessment report (EPAR): Eviplera, emtricitabine,rilpivirine,tenofovir disoproxil, Date of authorisation: 27/11/2011, Revision: 27, Status: Authorised

Human medicines European public assessment report (EPAR): Abecma, idecabtagene vicleucel, Date of authorisation: 18/08/2021, Revision: 14, Status: Authorised

EMEA-003580-PIP01-24

EMEA-003564-PIP01-23